| Patent | Date |
|---|
Anti-lag-3 Binding Molecules
App 20220220199 - TRIEBEL; Frederic ; et al. | 2022-07-14 |
Combination Therapies Comprising Antibody Molecules To Lag-3
App 20220153835 - DRANOFF; Glenn ; et al. | 2022-05-19 |
Cytotoxic Anti-lag-3 Monoclonal Antibody And Its Use In The Treatment Or Prevention Of Organ Transplant Rejection And Autoimmune Disease
App 20210317210 - HAUDEBOURG; Thomas ; et al. | 2021-10-14 |
Combined Preparations For The Treatment Of Cancer Or Infection
App 20210177937 - TRIEBEL; Frederic ; et al. | 2021-06-17 |
Combined preparations for the treatment of cancer or infection
Grant 10,940,181 - Triebel , et al. March 9, 2 | 2021-03-09 |
Antibody Molecules To Lag-3 And Uses Thereof
App 20210009687 - Triebel; Frederic ; et al. | 2021-01-14 |
Combined preparations for the treatment of cancer or infection
Grant 10,874,713 - Triebel , et al. December 29, 2 | 2020-12-29 |
Combined Preparations For The Treatment Of Cancer
App 20200323957 - Triebel; Frederic | 2020-10-15 |
Combined preparations for the treatment of cancer
Grant 10,736,940 - Triebel A | 2020-08-11 |
Antibody molecules to LAG-3 and uses thereof
Grant 10,711,060 - Triebel , et al. | 2020-07-14 |
Combined Preparations For The Treatment Of Cancer Or Infection
App 20200121757 - TRIEBEL; Frederic ; et al. | 2020-04-23 |
Use Of Recombinant Lag-3 Or The Derivatives Thereof For Eliciting Monocyte Immune Response
App 20190175726 - TRIEBEL; Frederic | 2019-06-13 |
Anti-lag-3 Antibodies
App 20190153112 - TRIEBEL; Frederic ; et al. | 2019-05-23 |
Cytotoxic Anti-lag-3 Monoclonal Antibody And Its Use In The Treatment Or Prevention Of Organ Transplant Rejection And Autoimmune Disease
App 20190135916 - HAUDEBOURG; Thomas ; et al. | 2019-05-09 |
Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response
Grant 10,232,038 - Triebel | 2019-03-19 |
Combination Therapies Comprising Antibody Molecules To Lag-3
App 20180340025 - Dranoff; Glenn ; et al. | 2018-11-29 |
Combined Preparations For The Treatment Of Cancer Or Infection
App 20180271940 - TRIEBEL; Frederic ; et al. | 2018-09-27 |
Antibody Molecules To Lag-3 And Uses Thereof
App 20180086830 - Triebel; Frederic ; et al. | 2018-03-29 |
Antibody molecules to LAG-3 and uses thereof
Grant 9,908,936 - Triebel , et al. March 6, 2 | 2018-03-06 |
Antibody Molecules To Lag-3 And Uses Thereof
App 20170210804 - Triebel; Frederic ; et al. | 2017-07-27 |
Use Of Recombinant Lag-3 Or The Derivatives Thereof For Eliciting Monocyte Immune Response
App 20170119876 - TRIEBEL; Frederic | 2017-05-04 |
Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response
Grant 9,579,382 - Triebel February 28, 2 | 2017-02-28 |
Combined Preparations For The Treatment Of Cancer
App 20160310570 - TRIEBEL; Frederic | 2016-10-27 |
Cytotoxic Anti-lag-3 Monoclonal Antibody And Its Use In The Treatment Or Prevention Of Organ Transplant Rejection And Autoimmune Disease
App 20160176965 - Haudebourg; Thomas ; et al. | 2016-06-23 |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
Grant 9,244,059 - Triebel , et al. January 26, 2 | 2016-01-26 |
Antibody Molecules To Lag-3 And Uses Thereof
App 20150259420 - Triebel; Frederic ; et al. | 2015-09-17 |
Nucleotide sequence coding for variable regions of .beta. chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
Grant 8,709,426 - Hercend , et al. April 29, 2 | 2014-04-29 |
Compositions containing LAG-3 and cells that secrete GM-CSF and methods of use
Grant 8,425,897 - Jooss , et al. April 23, 2 | 2013-04-23 |
Cytotoxic Anti-lag-3 Monoclonal Antibody And Its Use In The Treatment Or Prevention Of Organ Transplant Rejection And Autoimmune Disease
App 20110070238 - TRIEBEL; FREDERIC ; et al. | 2011-03-24 |
Use Of Recombinant Lag-3 Or The Derivatives Thereof For Eliciting Monocyte Immune Response
App 20110008331 - Triebel; Frederic | 2011-01-13 |
Cytotoxic Anti-lag-3 Monoclonal Antibody And Its Use In The Treatment Or Prevention Of Organ Transplant Rejection And Autoimmune Disease
App 20100233183 - Triebel; Frederic ; et al. | 2010-09-16 |
Apc Activators In Combination With A Cytokine-secreting Cell And Methods Of Use Thereof
App 20090130054 - Jooss; Karin ; et al. | 2009-05-21 |
Nucleotide Sequence Coding For Variable Regions Of Beta Chains Of Human T Lymphocyte Receptors, Corresponding Peptide Segments And The Diagnostic And Therapeutic Uses
App 20080069770 - HERCEND; Thierry ; et al. | 2008-03-20 |
Vaccine Composition Comprising a Class II Cmh Lignd Coupled With an Antigen, Method for the Preparation and the Use Thereof
App 20080003235 - Triebel; Frederic | 2008-01-03 |
Nucleotide sequences coding for variable regions of .beta. chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
Grant 7,294,712 - Hercend , et al. November 13, 2 | 2007-11-13 |
Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
Grant 7,109,026 - Triebel September 19, 2 | 2006-09-19 |
Peptide compounds derived from a shifted ORF of the iCE gene
Grant 6,875,844 - Ronsin , et al. April 5, 2 | 2005-04-05 |
Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy
Grant 6,855,802 - Triebel , et al. February 15, 2 | 2005-02-15 |
Molecules binding to Glu-Pro motifs, therapeutic compositions containing them and their applications
App 20040171551 - Triebel, Frederic | 2004-09-02 |
Use of particle vectors in immunomodulation
App 20040081686 - Kravtzoff, Roger ; et al. | 2004-04-29 |
Soluble polypeptide fractions of the LAG-3 protein, production method, therapeutic composition, anti-idiotype antibodies
Grant RE38,313 - Faure , et al. November 11, 2 | 2003-11-11 |
Nucleotide sequences coding for variable regions of the alpha chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
Grant 6,596,536 - Hercend , et al. July 22, 2 | 2003-07-22 |
Nucleotide sequences coding for variable regions of beta chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
App 20030068628 - Hercend, Thierry ; et al. | 2003-04-10 |
Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
App 20020192195 - Triebel, Frederic | 2002-12-19 |
Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants
Grant 6,482,925 - El Tayar , et al. November 19, 2 | 2002-11-19 |
Therapeutic composition containing antibodies to soluble polypeptide fractions of LAG-3 protein
Grant 6,143,273 - Faure , et al. November 7, 2 | 2000-11-07 |
Proteins produced by human lymphocytes DNA sequence encoding these proteins and their pharmaceutical and biological uses
Grant 5,976,877 - Hercend , et al. November 2, 1 | 1999-11-02 |
Soluble polypeptide fractions of the LAG-3 protein, production method, therapeutic composition, anti-idiotype antibodies
Grant 5,955,300 - Faure , et al. September 21, 1 | 1999-09-21 |
DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3
Grant 5,874,250 - Hercend , et al. February 23, 1 | 1999-02-23 |
Proteins produced by human lymphocytes, DNA sequence encoding these proteins and their pharmaceutical and biological use
Grant 5,773,578 - Hercend , et al. June 30, 1 | 1998-06-30 |
| 